Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate whether the pharmacokinetics of atorvastatin and/or
its metabolites is altered in patients with confirmed atorvastatin-induced myopathy compared
to healthy controls.